A novel patient-derived pancreatic acinar cell carcinoma cell line shows high sensitivity to bortezomib

1.

Morohoshi T, Held G and Klöppel G. Exocrine pancreatic tumours and their

histological classification. A study based on 167 autopsy and 97 surgical cases.

Histopathology. 1983;7(5):645-61.

2.

Chen J and Baithun SI. Morphological study of 391 cases of exocrine

pancreatic tumours with special reference to the classification of exocrine

pancreatic carcinoma. J Pathol. 1985;146(1):17-29.

3.

Klimstra DS, Heffess CS, Oertel JE and Rosai J. Acinar Cell Carcinoma of the

Pancreas: A Clinicopathologic Study of 28 Cases. The American Journal of Surgical

Pathology. 1992;16(9):815-37.

4.

Holen KD, Klimstra DS, Hummer A, Gonen M, Conlon K, Brennan M, et al.

Clinical characteristics and outcomes from an institutional series of acinar cell

carcinoma of the pancreas and related tumors. J Clin Oncol. 2002;20(24):4673-8.

5.

Hoorens A, Lemoine NR, McLellan E, Morohoshi T, Kamisawa T, Heitz PU, et

al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53

expression, and Ki-ras mutation. The American Journal of Pathology.

1993;143(3):685-98.

6.

La Rosa S, Adsay V, Albarello L, Asioli S, Casnedi S, Franzi F, et al.

Clinicopathologic Study of 62 Acinar Cell Carcinomas of the Pancreas: Insights

Into the Morphology and Immunophenotype and Search for Prognostic Markers.

The American Journal of Surgical Pathology. 2012;36(12):1782-95.

7.

Lowery MA, Klimstra DS, Shia J, Yu KH, Allen PJ, Brennan MF, et al. Acinar

cell carcinoma of the pancreas: new genetic and treatment insights into a rare

malignancy. Oncologist. 2011;16(12):1714-20.

8.

Liu W, Shia J, Gönen M, Lowery MA, O’Reilly EM and Klimstra DS. DNA

Mismatch Repair Abnormalities in Acinar Cell Carcinoma of the Pancreas:

Frequency and Clinical Significance. Pancreas. 2014;43(8):1264-70.

9.

Richard C, Niogret J, Boidot R and Ghiringhelli F. EGFR amplification

induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma. World

J Gastrointest Oncol. 2018;10(4):103-7.

10. Abraham SC, Wu T-T, Hruban RH, Lee J-H, Yeo CJ, Conlon K, et al. Genetic

and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma. The

American Journal of Pathology. 2002;160(3):953-62.

11. Bergmann F, Aulmann S, Sipos B, Kloor M, von Heydebreck A, Schweipert J,

101

et al. Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57

cases. Virchows Arch. 2014;465(6):661-72.

12. Furlan D, Sahnane N, Bernasconi B, Frattini M, Tibiletti MG, Molinari F, et

al. APC alterations are frequently involved in the pathogenesis of acinar cell

carcinoma

of

the

pancreas,

mainly

through

gene

loss

and

promoter

hypermethylation. Virchows Arch. 2014;464(5):553-64.

13. Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, et al.

Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J

Pathol. 2014;232(4):428-35.

14. La Rosa S, Bernasconi B, Frattini M, Tibiletti MG, Molinari F, Furlan D, et al.

TP53 alterations in pancreatic acinar cell carcinoma: new insights into the

molecular pathology of this rare cancer. Virchows Arch. 2016;468(3):289-96.

15. Chmielecki J, Hutchinson KE, Frampton GM, Chalmers ZR, Johnson A, Shi

C, et al. Comprehensive genomic profiling of pancreatic acinar cell carcinomas

identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.

Cancer Discov. 2014;4(12):1398-405.

16. Furukawa T, Sakamoto H, Takeuchi S, Ameri M, Kuboki Y, Yamamoto T, et al.

Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in

acinar cell carcinomas of the pancreas. Sci Rep. 2015;5:8829.

17. Rao KN, Takahashi S and Shinozuka H. Acinar Cell Carcinoma of the Rat

Pancreas Grown in Cell Culture and in Nude Mice. Cancer Research.

1980;40(3):592.

18. Ornitz DM HR, Messing A, Palmiter RD, Brinster RL. Pancreatic neoplasia

induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science.

1987:188-93.

19. Kong B, Cheng T, Qian C, Wu W, Steiger K, Cao J, et al. Pancreas-specific

activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell

carcinoma. Mol Cancer. 2015;14:212-.

20. Rezaei M, Hosseini A, Nikeghbalian S and Ghaderi A. Establishment and

characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from

pancreas. Pancreatology. 2017;17(2):303-9.

21. Yamaguchi N, Yamamura Y, Koyama K, Ohtsuji E, Imanishi J and Ashihara

T. Characterization of New Human Pancreatic Cancer Cell Lines Which Propagate

in a Protein-free Chemically Defined Medium. Cancer Research. 1990;50(21):700814.

102

22. Armstrong MD, Von Hoff D, Barber B, Marlow LA, von Roemeling C, Cooper

SJ, et al. An effective personalized approach to a rare tumor: prolonged survival in

metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line

development. Journal of Cancer. 2011;2:142-52.

23. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et

al. Single Lgr5 stem cells build crypt-villus structures in vitro without a

mesenchymal niche. Nature. 2009;459(7244):262-5.

24. Sato T, Stange DE, Ferrante M, Vries RGJ, van Es JH, van den Brink S, et al.

Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma,

Adenocarcinoma, and Barrett's Epithelium. Gastroenterology. 2011;141(5):176272.

25. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al.

In Vitro Expansion of Human Gastric Epithelial Stem Cells and Their Responses

to Bacterial Infection. Gastroenterology. 2015;148(1):126-36.e6.

26. Chen Y-W, Huang SX, de Carvalho ALRT, Ho S-H, Islam MN, Volpi S, et al. A

three-dimensional model of human lung development and disease from pluripotent

stem cells. Nature Cell Biology. 2017;19(5):542-9.

27. Schumacher MA, Aihara E, Feng R, Engevik A, Shroyer NF, Ottemann KM,

et al. The use of murine-derived fundic organoids in studies of gastric physiology.

J Physiol. 2015;593(8):1809-27.

28. Onuma K, Ochiai M, Orihashi K, Takahashi M, Imai T, Nakagama H, et al.

Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc Natl Acad

Sci U S A. 2013;110(27):11127-32.

29. Sato T, Morita M, Tanaka R, Inoue Y, Nomura M, Sakamoto Y, et al. Ex vivo

model of non-small cell lung cancer using mouse lung epithelial cells. Oncol Lett.

2017;14(6):6863-8.

30. Ochiai M, Yoshihara Y, Maru Y, Matsuura T, Izumiya M, Imai T, et al. Krasdriven

heterotopic

tumor

development

from

hepatobiliary

organoids.

Carcinogenesis. 2019;40(9):1142-52.

31. Matsuura T, Maru Y, Izumiya M, Hoshi D, Kato S, Ochiai M, et al. Organoidbased ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.

Carcinogenesis. 2019;41(4):490-501.

32. Naruse M, Masui R, Ochiai M, Maru Y, Hippo Y and Imai T. An organoidbased

carcinogenesis

model

induced

Carcinogenesis. 2020.

103

by

in

vitro

chemical

treatment.

33. Boj Sylvia F, Hwang C-I, Baker Lindsey A, Chio Iok In C, Engle Dannielle D,

Corbo V, et al. Organoid Models of Human and Mouse Ductal Pancreatic Cancer.

Cell. 2015;160(1):324-38.

34. Li X, Francies HE, Secrier M, Perner J, Miremadi A, Galeano-Dalmau N, et

al. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity

providing a model for clonality studies and precision therapeutics. Nature

Communications. 2018;9(1):2983.

35. Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A Comprehensive

Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity

and Enables Therapeutic Screening. Cell Stem Cell. 2018;23(6):882-97 e11.

36. Maru Y, Tanaka N, Itami M and Hippo Y. Efficient use of patient-derived

organoids as a preclinical model for gynecologic tumors. Gynecologic Oncology.

2019;154(1):189-98.

37. Maru Y, Kawata A, Taguchi A, Ishii Y, Baba S, Mori M, et al. Establishment

and Molecular Phenotyping of Organoids from the Squamocolumnar Junction

Region of the Uterine Cervix. Cancers. 2020;12(3).

38. Maru Y, Tanaka N, Ebisawa K, Odaka A, Sugiyama T, Itami M, et al.

Establishment and characterization of patient-derived organoids from a young

patient with cervical clear cell carcinoma. Cancer Science. 2019;110(9):2992-3005.

39. Maru Y, Onuma K, Ochiai M, Imai T and Hippo Y. Shortcuts to intestinal

carcinogenesis

by

genetic

engineering

in

organoids.

Cancer

Science.

2019;110(3):858-66.

40. Shimozato O, Waraya M, Nakashima K, Souda H, Takiguchi N, Yamamoto H,

et al. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates

CD133 and regulates downstream AKT activation. Oncogene. 2015;34(15):1949-60.

41. Maru Y, Orihashi K and Hippo Y. Lentivirus-Based Stable Gene Delivery into

Intestinal Organoids. In: Ivanov AI, editor. Gastrointestinal Physiology and

Diseases: Methods and Protocols. New York, NY: Springer New York; 2016. p. 1321.

42. La Rosa S, Franzi F, Marchet S, Finzi G, Clerici M, Vigetti D, et al. The

monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of

pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Archiv.

2008;454(2):133.

43. Immervoll H, Hoem D, Sakariassen PØ, Steffensen OJ and Molven A.

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal

104

adenocarcinomas. BMC Cancer. 2008;8(1):48.

44. Immervoll H, Hoem D, Steffensen OJ, Miletic H and Molven A. Visualization

of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas:

non-overlapping membrane expression in cell populations positive for both

markers. J Histochem Cytochem. 2011;59(4):441-55.

45. Kim W-T and Ryu CJ. Cancer stem cell surface markers on normal stem cells.

BMB Rep. 2017;50(6):285-98.

46. Suwa H, Yoshimura T, Yamaguchi N, Kanehira K, Manabe T, Imamura M, et

al. K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic

adenocarcinoma cell lines. Jpn J Cancer Res. 1994;85(10):1005-14.

47. Hall JC, Marlow LA, Mathias AC, Dawson LK, Durham WF, Meshaw KA, et

al. Novel patient-derived xenograft mouse model for pancreatic acinar cell

carcinoma demonstrates single agent activity of oxaliplatin. J Transl Med.

2016;14(1):129.

48. Glazer ES, Neill KG, Frakes JM, Coppola D, Hodul PJ, Hoffe SE, et al.

Systematic Review and Case Series Report of Acinar Cell Carcinoma of the

Pancreas. Cancer Control. 2016;23(4):446-54.

49. Hideshima T, Richardson PG and Anderson KC. Mechanism of Action of

Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of

Synergy in Multiple Myeloma. Molecular Cancer Therapeutics. 2011;10(11):2034.

50. Takahashi K, Inukai T, Imamura T, Yano M, Tomoyasu C, Lucas DM, et al.

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell

lines. PLOS ONE. 2017;12(12):e0188680.

51. Dawson MA, Opat SS, Taouk Y, Donovan M, Zammit M, Monaghan K, et al.

Clinical and immunohistochemical features associated with a response to

bortezomib in patients with multiple myeloma. Clin Cancer Res. 2009;15(2):71422.

52. Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, et al. Is bortezomib,

a proteasome inhibitor, effective in treating cancer-associated weight loss?

Preliminary results from the North Central Cancer Treatment Group. Supportive

Care in Cancer. 2005;13(6):381-6.

53. Wang H, Cao Q and Dudek AZ. Phase II study of panobinostat and bortezomib

in patients with pancreatic cancer progressing on gemcitabine-based therapy.

Anticancer Res. 2012;32(3):1027-31.

54. Märten A, Zeiss N, Serba S, Mehrle S, von Lilienfeld-Toal M and Schmidt J.

105

Bortezomib is ineffective in an orthotopic mouse model of pancreatic

adenocarcinoma. Molecular Cancer Therapeutics. 2008;7(11):3624-31.

55. Ding L, Han L, Li Y, Zhao J, He P and Zhang W. Neurogenin 3-directed cre

deletion

of

Tsc1

gene

causes

pancreatic

acinar

carcinoma.

Neoplasia.

2014;16(11):909-17.

56. Jakel C, Bergmann F, Toth R, Assenov Y, van der Duin D, Strobel O, et al.

Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas

reveal aberrations in genome stability. Nat Commun. 2017;8(1):1323.

57. Juhász S, Elbakry A, Mathes A and Löbrich M. ATRX Promotes DNA Repair

Synthesis and Sister Chromatid Exchange during Homologous Recombination.

Molecular Cell. 2018;71(1):11-24.e7.

58. Houbracken I, de Waele E, Lardon J, Ling Z, Heimberg H, Rooman I, et al.

Lineage tracing evidence for transdifferentiation of acinar to duct cells and

plasticity of human pancreas. Gastroenterology. 2011;141(2):731-41, 41.e1-4.

106

...